Gabapentin enhances the analgesic effect of morphine in healthy volunteers

Anesthesia and Analgesia

Volumn 91, Issue 1, 2000, Pages 185-191

  Eckhardt, Klaus ^a   Ammon, Susanne ^a   Hofmann, Ute ^a   Riebe, Anja ^a   Gugeler, Nadja ^a   Mikus, Gerd ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; MORPHINE;

ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; COLD PRESSOR TEST; DRUG ABSORPTION; DRUG ELIMINATION; DRUG POTENTIATION; DRUG TOLERABILITY; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SOMNOLENCE; VERTIGO; XEROSTOMIA;

EID: 0033918317     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200007000-00035     Document Type: Article

References (25)

1. Portenoy RK. Tolerance to opioid analgesics: clinical aspects. Cancer Surv 1994;21:49-65.
2. Dickenson A. Neurophysiology of opioid poorly responsive pain. Cancer Surv 1994;21:5-16.
3. Draw A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sci 1994;15:190-7.
4. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280:1831-6.
5. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
6. Field MJ, Holloman EF, McCleary S, et al. Evaluation of Gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 1997;282:1242-6.
7. Stanfa LC, Singh L, Williams RG, Dickenson AH. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 1997;8:587-90.
8. Chapman V, Suzuki R, Chamarette HL, et al. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998;75:261-72.
9. Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain, 1997;72:375-82.
10. Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy, Drugs 1993;46: 409-27.
11. Eckhardt K, Li S, Ammon S, et al. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain 1998;76:27-33.
12. Hengy H, Kolle EU. Determination of Gabapentin in plasma and urine by high-performance chromatography and precolumn labelling for ultraviolet detection. J Chromatogr 1985; 34:473-8.
13. Schaenzle G, Li S, Mikus G, Hofmann U. A rapid, highly sensitive method for determination of morphine and its metabolites in body fluids by liquid chromatography-mass spectrometry. J Chromatography-Biomed Appl 1999;721:55-65
14. Webb J, Kamali F. Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo controlled study in healthy volunteers. Pain 1998;76:357-63.
15. Partridge BJ, Chaplan SR, Sakamoto E, Yaksh TL. Characterization of the effects of Gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia. Anesthesiology 1998;86:196-205.
16. Grudt TJ, Williams JT. Opioid receptors and the regulation of ion conductances. Rev Neurosci 1995;6:279-88.
17. Taylor CP. Mechanisms of action of Gabapentin. Rev Neurol (Paris) 1997;153(Suppl 1):S39-45.
18. Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, Gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-76.
19. Hasegawa AE, Zacny JP. The influence of three L-type calcium channel blockers on morphine effects in healthy volunteers. Anesth Analg 1997;85:633-8.
20. Santillan R, Hurle MA, Armijo JA, et al. Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study. Pain 1998; 76:17-26.
21. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62:259-74.
22. Toelle TR, Castro-Lopes JM, Schadrack J, et al. Anticonvulsants suppress c-Fos protein expression in spinal cord neurons following noxious thermal stimulation. Exp Neurol 1995;132: 271-8.
23. Ohnishi T, Saito K, Maeda S, et al. Intracerebroventricular treatment of mice with pertussis toxin induces hyperalgesia and enhances 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance. Naunyn Schmiedebergs Arch Pharmacol 1990;341:123-7.
24. Patsalos PN, Duncan JS. Antiepileptic drugs: a review of clinically significant drug interactions. Drug Safety 1993;9:156-84.
25. Caraceni A, Zecca E, Martini C, de Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manag 1999;17:441-5.